Clinical Trial Update: Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of Insomnia [Phase 2, Phase 3]

View source ↗

Summary

A trial update comparing melatonin 3 mg and 5 mg to cognitive behavioral therapy for insomnia (CBT-I) in adults with Insomnia Disorder across Phase 2 and Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia Disorder

Drugs mentioned

• Melatonin 3 mg (melatonin)
• Melatonin 5 mg (melatonin)

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Insomnia Disorder | Phase 2, Phase 3 | Status: UNKNOWN